Seymour, MT (2011) Sequential Chemotherapy for Colorectal Cancer. Lancet Oncology, 12. 1 - 2 (2). ISSN 0140-6736
Full text available as:
Published Version: http://dx.doi.org/10.1016/S1470-2045(11)70233-9
Abstract
In The Lancet Oncology, Michel Ducreux and colleagues1 present data that—not for the first time—challenge the assumption that patients with incurable metastatic colorectal cancer should always receive the most active regimen available as first-line treatment.
| Item Type: | Article |
|---|---|
| Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Oncology and Clinical Research (Leeds) |
| Depositing User: | Symplectic Publications |
| Date Deposited: | 19 Sep 2011 10:06 |
| Last Modified: | 08 Feb 2013 17:34 |
| Published Version: | http://dx.doi.org/10.1016/S1470-2045(11)70233-9 |
| Status: | Published |
| Publisher: | Elsevier |
| Identification Number: | 10.1016/S1470-2045(11)70233-9 |
| URI: | http://eprints.whiterose.ac.uk/id/eprint/43232 |
Actions (login required)
 |
View Item |
